CELG laid out $12.50 in EPS for 2020. That is far beyond any expectation I had. With a simple 20 P/E on those earnings you get to $250. That is a very conservative estimate. This is easy a 115% gain over 5 years. Buy all dips cause that is the conservative estimates.
Sentiment: Strong Buy
Oil stocks and the big biotechs are in the market index ETF's. Momentum traders in the ETF's kill all stocks. Because the PE's on these stocks are high investors just holding CELG or REGN etc. sell because they know that the market is dragging them down. They may buy back in when the price drops or get into another quick mover. All these people are not investors but speculators. Back in the 1990's AMGN lost 20% of it's value in one day due to an article planted in the WSJ. I owned the stock and new the data were lies. I went on to make 10 times my investment, only selling to pay college tuition for children. If you are an investor and know what you own then don't worry about the noise. I just listened to the kick off speech by our CEO and this company is even a bigger monster than it was yesterday.
people who really understand biotechs and or celg, should not get too excited about one day move...good things continue to come for the company and its a long term hold. but to follow the developments of this company is pretty exciting.
They are doing OK today. It's just that the price of oil is pulling completely unrelated stocks down. When we got a couple days of oil stability last week, healthcare/biotech had nice gains. Then Friday it was back to falling oil and also today although these stocks are trying despite being pulled down by falling oil which is not only unrelated, it's a good thing overall to the economy. I don't understand how it works...
Hematology could get to 15B in sales by 2020 and I&I could reach 3B. That puts total sales for 2020 at 18B. That is 1B higher then even I was calling for. Bob said that was a conservative outlook so this could reach 20B in sales by 2020.
yes I know but he is to be on cnbc soon this morning. I would like to see what he said at JPM HCC. I am sure there will be a recap on here ;)
If you don't know how 2020 estimate helps anyone today, then you don't know what investing is all about. Stocks/companies trade on future earnings and knowing where a company will get those future earnings from is the golden ticket. By the way 2020 is only 4-5 years away. What is investing to you? Next week, next month. Go back to school and learn something.
Sentiment: Strong Buy
All stocks trade on future earnings. The percent change year over year is used to determine valuation. The market also likes predictability and if you can forecast a few years into the future investors are better able to determine valuation. In CELG's case they seem to underestimate and over deliver.
After starting and closing out positions successfully in each of the past two weeks, I don't have a position in CELG, so I don't have a bias based on holdings. I don't understand how an estimate of where CELG might be in 2020 helps anyone.
if you take the splits into consideration, well, it would be well above 600 right now. so its gonna split again when it goes 160 sometime next year.
Yes, CELG will grow revenue from around 7B in 2014 to around 17B by 2020. That is 2.5 times what it is worth today.
No I am saying you have no clue. Your numbers prove it. This not about one type of cancer but many. You can say what you want, put your $ where you want, I don't care. I have no time to engage you, and do your DD for you.
So basically your saying you have no clue except of hope and wishful thinking. Every indication combine for both drugs comes out to an addressable market of about 50k people world wide.